Glucose responsive insulin secreting .beta.-cell lines and method for producing same
US5773255A · kind A · utility
18Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | Jun 30, 1998 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2500/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A line of .beta. cells is described which is capable of maintaining high levels of insulin secretion in culture. Such cells are useful in the treatment of diabetes, for example, by encapsulation of the cells in an insulin-permeable membrane device, followed by implantation into a diabetes patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.